Metastatic and locally aggressive BCC: Current treatment options

The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.

Detalles Bibliográficos
Autores principales: Casey, Máire‐Caitlín, Pollock, Roisín, Enright, Rachel H, O'Neill, James Paul, Shine, Neville, Sullivan, Paul, Martin, Fiachra T, O'Sullivan, Barry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517578/
https://www.ncbi.nlm.nih.gov/pubmed/34691462
http://dx.doi.org/10.1002/ccr3.4965
Descripción
Sumario:The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.

Ejemplares similares